Moderna Stand-ready manufacturing revenue — Total Revenue increased by 166.7% to $32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 166.7%, from $12.00M to $32.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful monetization of manufacturing infrastructure and expanded strategic partnerships, while a decrease may signal the expiration of capacity-reservation contracts or a shift in partnership strategy.
This metric represents revenue generated from contractual arrangements where the company maintains manufacturing capacit...
Similar to contract manufacturing organization (CMO) service fees or capacity reservation payments found in other large-scale biopharmaceutical or industrial manufacturing firms.
mrna_segment_stand_ready_manufacturing_revenue_total_revenue| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.00M | $32.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +166.7% |
| YoY Change | — | — | — | — | — | — | — | — | — | +166.7% |